Hyperammonaemia in classic organic acidaemias: a review of the literature and two case histories

Abstract Background The ‘classic’ organic acidaemias (OAs) (propionic, methylmalonic and isovaleric) typically present in neonates or infants as acute metabolic decompensation with encephalopathy. This is frequently accompanied by severe hyperammonaemia and constitutes a metabolic emergency, as incr...

Full description

Bibliographic Details
Main Authors: Johannes Häberle, Anupam Chakrapani, Nicholas Ah Mew, Nicola Longo
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13023-018-0963-7
_version_ 1818490834853560320
author Johannes Häberle
Anupam Chakrapani
Nicholas Ah Mew
Nicola Longo
author_facet Johannes Häberle
Anupam Chakrapani
Nicholas Ah Mew
Nicola Longo
author_sort Johannes Häberle
collection DOAJ
description Abstract Background The ‘classic’ organic acidaemias (OAs) (propionic, methylmalonic and isovaleric) typically present in neonates or infants as acute metabolic decompensation with encephalopathy. This is frequently accompanied by severe hyperammonaemia and constitutes a metabolic emergency, as increased ammonia levels and accumulating toxic metabolites are associated with life-threatening neurological complications. Repeated and frequent episodes of hyperammonaemia (alongside metabolic decompensations) can result in impaired growth and intellectual disability, the severity of which increase with longer duration of hyperammonaemia. Due to the urgency required, diagnostic evaluation and initial management of patients with suspected OAs should proceed simultaneously. Paediatricians, who do not have specialist knowledge of metabolic disorders, have the challenging task of facilitating a timely diagnosis and treatment. This article outlines how the underlying pathophysiology and biochemistry of the organic acidaemias are closely linked to their clinical presentation and management, and provides practical advice for decision-making during early, acute hyperammonaemia and metabolic decompensation in neonates and infants with organic acidaemias. Clinical management The acute management of hyperammonaemia in organic acidaemias requires administration of intravenous calories as glucose and lipids to promote anabolism, carnitine to promote urinary excretion of urinary organic acid esters, and correction of metabolic acidosis with the substitution of bicarbonate for chloride in intravenous fluids. It may also include the administration of ammonia scavengers such as sodium benzoate or sodium phenylbutyrate. Treatment with N-carbamyl-L-glutamate can rapidly normalise ammonia levels by stimulating the first step of the urea cycle. Conclusions Our understanding of optimal treatment strategies for organic acidaemias is still evolving. Timely diagnosis is essential and best achieved by the early identification of hyperammonaemia and metabolic acidosis. Correcting metabolic imbalance and hyperammonaemia are critical to prevent brain damage in affected patients.
first_indexed 2024-12-10T17:22:47Z
format Article
id doaj.art-92793fe7f92442e2abeeadb29be96ef6
institution Directory Open Access Journal
issn 1750-1172
language English
last_indexed 2024-12-10T17:22:47Z
publishDate 2018-12-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj.art-92793fe7f92442e2abeeadb29be96ef62022-12-22T01:39:56ZengBMCOrphanet Journal of Rare Diseases1750-11722018-12-0113111010.1186/s13023-018-0963-7Hyperammonaemia in classic organic acidaemias: a review of the literature and two case historiesJohannes Häberle0Anupam Chakrapani1Nicholas Ah Mew2Nicola Longo3Division of Metabolism and Children’s Research Centre, University Children’s Hospital ZurichDepartment of Clinical Inherited Metabolic Disorders, Great Ormond Street Hospital for Children NHS Foundation TrustChildren’s National Rare Disease Institute, Children’s National Health SystemDepartment of Pediatrics, Division of Medical Genetics, University of Utah School of MedicineAbstract Background The ‘classic’ organic acidaemias (OAs) (propionic, methylmalonic and isovaleric) typically present in neonates or infants as acute metabolic decompensation with encephalopathy. This is frequently accompanied by severe hyperammonaemia and constitutes a metabolic emergency, as increased ammonia levels and accumulating toxic metabolites are associated with life-threatening neurological complications. Repeated and frequent episodes of hyperammonaemia (alongside metabolic decompensations) can result in impaired growth and intellectual disability, the severity of which increase with longer duration of hyperammonaemia. Due to the urgency required, diagnostic evaluation and initial management of patients with suspected OAs should proceed simultaneously. Paediatricians, who do not have specialist knowledge of metabolic disorders, have the challenging task of facilitating a timely diagnosis and treatment. This article outlines how the underlying pathophysiology and biochemistry of the organic acidaemias are closely linked to their clinical presentation and management, and provides practical advice for decision-making during early, acute hyperammonaemia and metabolic decompensation in neonates and infants with organic acidaemias. Clinical management The acute management of hyperammonaemia in organic acidaemias requires administration of intravenous calories as glucose and lipids to promote anabolism, carnitine to promote urinary excretion of urinary organic acid esters, and correction of metabolic acidosis with the substitution of bicarbonate for chloride in intravenous fluids. It may also include the administration of ammonia scavengers such as sodium benzoate or sodium phenylbutyrate. Treatment with N-carbamyl-L-glutamate can rapidly normalise ammonia levels by stimulating the first step of the urea cycle. Conclusions Our understanding of optimal treatment strategies for organic acidaemias is still evolving. Timely diagnosis is essential and best achieved by the early identification of hyperammonaemia and metabolic acidosis. Correcting metabolic imbalance and hyperammonaemia are critical to prevent brain damage in affected patients.http://link.springer.com/article/10.1186/s13023-018-0963-7Metabolic acidosisHyperammonaemiaOrganic acidaemiasMetabolic decompensationBiochemical pathogenesis
spellingShingle Johannes Häberle
Anupam Chakrapani
Nicholas Ah Mew
Nicola Longo
Hyperammonaemia in classic organic acidaemias: a review of the literature and two case histories
Orphanet Journal of Rare Diseases
Metabolic acidosis
Hyperammonaemia
Organic acidaemias
Metabolic decompensation
Biochemical pathogenesis
title Hyperammonaemia in classic organic acidaemias: a review of the literature and two case histories
title_full Hyperammonaemia in classic organic acidaemias: a review of the literature and two case histories
title_fullStr Hyperammonaemia in classic organic acidaemias: a review of the literature and two case histories
title_full_unstemmed Hyperammonaemia in classic organic acidaemias: a review of the literature and two case histories
title_short Hyperammonaemia in classic organic acidaemias: a review of the literature and two case histories
title_sort hyperammonaemia in classic organic acidaemias a review of the literature and two case histories
topic Metabolic acidosis
Hyperammonaemia
Organic acidaemias
Metabolic decompensation
Biochemical pathogenesis
url http://link.springer.com/article/10.1186/s13023-018-0963-7
work_keys_str_mv AT johanneshaberle hyperammonaemiainclassicorganicacidaemiasareviewoftheliteratureandtwocasehistories
AT anupamchakrapani hyperammonaemiainclassicorganicacidaemiasareviewoftheliteratureandtwocasehistories
AT nicholasahmew hyperammonaemiainclassicorganicacidaemiasareviewoftheliteratureandtwocasehistories
AT nicolalongo hyperammonaemiainclassicorganicacidaemiasareviewoftheliteratureandtwocasehistories